O
Ovid Therapeutics Inc. (OVID)
NCM – Real Time Price. Currency in USD
2.87
+0.08 (2.87%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
2.87
+0.08 (2.87%)
At close: May 12, 2026, 4:00 PM EDT
Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of small molecule medicines for brain disorders including epilepsies and seizure-related neurological disorders in the United States. The company is developing OV329, a GABA-AT inhibitor which is in Phase 1 clinical trials for the treatment of adult and infant drug-resistant epilepsies; and OV4071, a first-in-human oral potassium-chloride cotransporter 2 direct activator which is in Phase 1 clinical trials for the treatment of psychosis associated with parkinson's disease, lewy body dementia, and acute schizophrenia. It has license and collaboration agreements with AstraZeneca AB, H. Lundbeck A/S, Northwestern University, and Graviton, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.
| Name | Position |
|---|---|
| Dr. Jeremy Max Levin Ba Zoology, Dphil, M.D., Mb Bchir, Ph.D. | Co-Founder & Executive Chairman |
| Dr. Julia Tsai Ph.D. | Senior Vice President of Clinical Development |
| Dr. Manal Morsy M.B.A., M.D., PH.D. | Chief Regulatory Officer |
| Dr. Petra Kaufmann M.D., M.S. | Chief Medical Officer |
| Dr. Toshiya Nishi D.V.M. | Head of Epilepsy Research |
| Dr. Zhong Zhong Ph.D. | Chief Scientific Officer |
| Mr. Charles Ross Carter | Senior VP of Finance & Financial Planning |
| Mr. Jeffrey A. Rona | Chief Business & Financial Officer and Corporate Secretary |
| Ms. Margaret Alexander | CEO, President & Director |
| Ms. Victoria Fort | Senior Vice President of Corporate Affairs & Corporate Strategy |
| Date | Type | Document |
|---|---|---|
| 2026-04-27 | DEFA14A | ovid-20260427.htm |
| 2026-04-21 | S-3 | d108102ds3.htm |
| 2026-04-20 | 8-K | ovid-20260420.htm |
| 2026-03-18 | S-8 | ovids-82026x03x17.htm |
| 2026-03-18 | 10-K | ovid-20251231.htm |
| 2025-12-19 | CORRESP | filename1.htm |
| 2025-12-18 | 8-K | d84904d8k.htm |
| 2025-12-15 | S-3 | d35579ds3.htm |
| 2025-12-11 | 8-K | ovid-20251211.htm |
| 2025-11-12 | 10-Q | ovid-20250930.htm |